Abstract: Chronic non-healing wounds including diabetic, venous, and decubitus skin ulcers are currently lacking effective therapies. Non-healing diabetic ulcers can lead to amputations as progress into a highly chronic state before detection and existing treatments for these wounds often fail. Granzyme B (GzmB) is a serine protease that was, until recently, believed to function exclusively in cytotoxic lymphocyte-mediated apoptosis. However, during excessive or chronic inflammation, GzmB can accumulate in the extracellular milieu, retain its activity, and cleave a number of important extracellular proteins. Epidermal growth factor receptor (EGFR) is a transmembrane receptor involved in cellular processes such as proliferation and migration. EGFR signaling is integral to the wound healing process. The present study investigated the effects of GzmB on keratinocyte cell migration using HaCaT cell line. Using electric cellsubstrate impedance sensing and scratch assays, the present study demonstrates that GzmB inhibits keratinocyte migration by interfering with the EGFR pathway. GzmB limited cell transition into a migratory morphology and was found to reduce ligand-induced EGFR phosphorylation. Inhibition of GzmB reversed the aforementioned effects. In summary, data from the present study suggest key role for GzmB in the pathogenesis of impaired wound healing through the impairment of EGFR signaling and cell migration.
Introduction
Chronic non-healing wounds including diabetic, venous, and decubitus skin ulcers are a persisting problem due to the lack of effective therapies (Pradhan et al., 2007) , with annual cost of treatment in the US in excess of $25 billion (Fan et al., 2011) . These wounds can arise as a result of many factors including vascular or neurological insufficiencies, immobility, old age, and the presence of underlying pathologies such as diabetes or arteriosclerosis (Mustoe et al., 2006; Sen et al., 2009) . With increasing aging and diabetic populations the number of patients suffering from non-healing wounds keeps growing (Sen et al., 2009) . Thus investigating the pathogenic mechanisms behind chronic wound healing to identify potential drug targets to enhance wound healing remains an unmet need.
Physiological wound healing consists of tightly regulated and overlapping phases of hemostasis, inflammation, granulation tissue formation and re-epithelialization, and tissue remodeling (O'Toole and Mellerio, 2010) . After the basement membrane is established during granulation tissue formation, the re-epithelialization process is heavily dependent on successful migration of keratinocytes towards the center of the wound (O'Toole and Mellerio, 2010) . Cell migration is a complex process involving phenotypic changes of migratory cells (Seeger and Paller, 2015) . These changes include dissolution of cell-to-cell contacts, cytoskeletal rearrangements and membrane spreading, as well as change in cell polarity and the formation of lamellipodia (Horwitz and Webb, 2003; Petrie et al., 2009; Seeger and Paller, 2015) . Epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase receptor essential for the signaling required for the induction of migratory and proliferative pathways (Haase et al., 2003; Harris et al., 2003) . During wound healing, keratinocytes initiate EGFR signaling through ectodomain shedding (Harris et al., 2003) of the epidermal growth factor (EGF) -the EGFR-specific ligand, however, other sources of EGF, such as platelets, are also available during early stages of wound healing (Szpaderska et al., 2003; Hardwicke et al., 2008) . Upon ligand binding a conformational change occurs allowing two molecules of EGFR to dimerize and autophosphorylate intracellular C-terminal domains, leading to downstream signal transduction (Dawson et al., 2005; Higashiyama et al., 2008) . It is believed that in a chronic or pathological wound environment where there is high proteolytic activity, EGF is degraded or becomes trapped by proteolytic fragments generated in the chronic wound and limits the required signaling (Hardwicke et al., 2008) .
Granzymes belong to the family serine proteases that, while sharing structural similarities, possess diverse substrate specificities (Boivin et al., 2009 ). There are five Granzymes in humans: Granzyme A, B, H, K and M (Boivin et al., 2009) . Granzymes A and B are the most widely studied due to their high abundance and roles in cellmediated immune response (Boivin et al., 2009 ). Granzyme B (GzmB), once believed to function primarily in the perforin-dependent lymphocyte-mediated killing of target cells, is now recognized to exhibit extracellular proteolytic activity in conditions associated with impaired wound healing (Hiebert and Granville, 2012) . Indeed, recent studies show that GzmB also possesses extracellular, perforin-independent roles (Hendel et al., 2010; Hiebert and Granville, 2012; Hiebert et al., 2013) . During dysregulated inflammation, GzmB can accumulate in the extracellular milieu, retain its activity, and cleave extracellular matrix proteins including fibronectin, vitronectin, decorin, and laminin (Choy et al., 2004; Buzza et al., 2005; Boivin et al., 2012; Hiebert and Granville, 2012) . Our laboratory previously showed that GzmB inhibition using either a knockout model or with Serpin a3n promoted wound closure in murine models of delayed wound healing (Hiebert et al., 2013; Hsu et al., 2014) .
The present study aimed to investigate the direct effect of GzmB on keratinocytes during the migration stage of wound healing. GzmB impaired EGFR-mediated migration and limited the morphological change of keratinocytes towards a migratory phenotype. Additionally, GzmB reduced ligand-dependent phosphorylation of EGFR, however, GzmB did not cleave EGFR or EGF. The results of this study provide further insight into the roles of GzmB in cellular mechanisms involved in wound healing.
Results

Granzyme B impairs keratinocyte migration through an EGFR-dependent mechanism
HaCaT keratinocyte migration was assessed in vitro by electric cell-substrate impedance sensing (ECIS) and scratch assay. GmzB untreated/EGF stimulated cells migrated at a faster rate than untreated control cells, while GzmB treated/EGF unstimulated cells did not migrate ( Figure 1A) . Interestingly, the migration of GzmB treated/EGF stimulated cells was delayed by 8 h compared to GzmB untreated/EGF stimulated cells. The quantitative analysis further showed a 2-fold migration time delay in GzmB treated/EGF stimulated cells compared to GzmB untreated/EGF stimulated cells. GzmB inhibition with Serpina3n restored the migration phenotype to that of GmzB untreated/EGF stimulated cells ( Figure 1A ). Alternatively, migration was assessed by scratch assay ( Figure 1B ). In agreement with the ECIS results, GzmB reduced HaCaT migration in GzmB treated/EGF stimulated cells approximately 3-fold in comparison to GzmB untreated/EGF stimulated cells. Similarly, GzmB alone reduced cell migration in comparison to control treated cells.
GzmB impairs transition to migratory cell morphology
HaCaT cell morphology was examined at the wound edges of scratches made through the cell monolayers. GzmB treatment significantly reduced the number of cells that displayed a migratory phenotype (Figure 2A and B). In GzmB untreated/EGF stimulated group, more cells exhibited cell spreading with defined leading edges, cell polarity, and lamellipodia, which are characteristics of migrating cells (Bretscher, 2008; Keren et al., 2008) . HaCaT cells treated with 100 nm GzmB for 6 h were scratched, washed with PBS, then incubated for 18 h with fresh GzmB treated medium±100 ng/ml EGF. Cells were imaged at the time of scratching (0 h) and 18 h after scratching. Scratch areas from at least four independent experiments were quantified and expressed as a percentage relative to the scratch area at 0 h. For both experiments data was by one-way ANOVA followed by Tukey's multiple comparisons test and is represented as mean values ±SEM; *p < 0.05, **p < 0.001.
GzmB reduces ligand-induced EGFR phosphorylation
To investigate whether the functional changes in HaCaT cells were a direct result of EGFR signaling, EGFR phosphorylation levels were assessed by western immuno blotting after treating cells with GzmB. GzmB significantly reduced ligand-dependent EGFR phosphorylation in a dose dependent manner ( Figure 3A ). Inhibiting GzmB with Sa3n restored P-EGFR level to that observed in controls. The same effect on P-EGFR was observed in HeLa cells ( Figure 3B ). The presence of cycloheximide, a protein synthesis blocker, did not affect the ability of GzmB to reduce P-EGFR levels ( Figure 3C ). In this experiment, p53 was used as a control protein due to its short half-life (Giaccia and Kastan, 1998) . Interestingly, treatment of HaCaT cells with GzmK, another member of GzmB family, following EGF stimulation did not lead to a reduction in P-EGFR levels ( Figure 3D ). 
GzmB does not cleave EGF or the extracellular domain of EGFR
To determine whether the cleavage of EGFR or its ligand by GzmB was responsible for EGF-induced P-EGFR reduction, biochemical cleavage assays were performed. GzmB did not cleave EGF as determined by protein gel staining where no EGF band intensity changes were observed between control and GzmB containing reactions ( Figure 4A ). GzmB did not cleave the extracellular domain of EGFR as determined by western immunoblotting ( Figure 4B ) and protein gel staining ( Figure 4C ).
GzmB does not reduce HaCaT cell viability
GzmB has previously been shown to induce anoikis in breast carcinoma, endothelial and smooth muscle cells (Choy et al., 2004; Buzza et al., 2005) . A downstream effector of anoikis, caspase-3 has been shown to cleave the C-terminus of EGFR and reduce its activity (Bae et al., (A) HaCaT (B) HeLa cells were treated with increasing concentrations of GzmB for 6 h followed by a 10-min stimulation with 100 ng/ml EGF. Western Blot was done using antibodies for P-EGFR (Y1068), EGFR, and GAPDH. Bar graph shows EGFR phosphorylation levels expressed as percentages relative to total EGFR levels as determined by semi-quantitative band intensity analysis. Serpina3n was used to inhibit GzmB activity in (A). Data in (A) was analyzed by a two-tailed, unpaired Mann-Whitney test and is represented as mean values±SEM, *p < 0.05. (C) GzmB-induced P-EGFR response analyzed in HaCaT cells pre-treated with 10 μg/μl cycloheximide (using p53 as a short half-life control) for 24 h prior to the start of experiment done following the procedure in (A). (D) Western immunoblotting of HaCaT cell lysates following a 6-h treatment with 100 nm GzmK and a 10-min stimulation with 100 ng/ml EGF. Western blots shown represent results of at least 3 independent independent experiments.
2001; He et al., 2006; Simpson et al., 2008) . We investigated whether induction of anoikis and caspase-3 were involved in GzmB-dependent reduction in P-EGFR levels. Cell viability after GzmB treatment was assessed by AnnexinV/PI staining and flow cytometry. GzmB did not induce apoptosis in HaCaT cells over the period of 6 and 24 h ( Figure 5A ). Additionally, GzmB did not reduce cell viability as determined by calcein viability assay after 6 and 24 h (Supplementary Figure 1) . To further rule out the potential involvement of caspase-3 in reducing P-EGFR levels, a caspase-3 deficient MCF-7 epithelial cell line was treated with GzmB and stimulated with EGF which still resulted in the reduction of P-EGFR levels ( Figure  5B ). Additionally, cleaved caspase-3 was not detected by Western immunoblotting in HaCaT cells after 6 and 24 h of 100 nm GzmB treatment (data not shown). 
GzmB-treated HaCaT cells lack actin rearrangements required for migration
To further examine the migratory cell phenotype lacking in cells following GzmB treatment, actin cytoskeleton architecture was assessed in HaCaT cells using immunofluorescent staining and confocal microscopy. In a confluent cell layer, filamentous actin (F-actin) is evenly distributed across the cell, maintaining its symmetrical shape. During migration, F-actin undergoes coordinated polymerization to extend cellular processes (filopodia and lamellipodia) towards the acellular space (Mattila and Lappalainen, 2008) . Filopodia are thin finger like projections filled with tight parallel strands of F-actin, while lamellipodia are filled with interlocking branches of F-actin (Pollard and Borisy, 2003) . During migration actin filament rearrangements push and extend the cell membrane forward in the direction of migration.
In the absence of GzmB, the majority of cells at the leading edge displayed clear actin spikes protruding towards the scratch zone creating a clear phenotypic difference between edge cells and cells within the monolayer ( Figure 6A and B) . Closer examination of the actin spikes revealed a thin parallel arrangement characteristic of filopodia ( Figure 6B ). With GzmB treatment, leading edge cells exhibited reduced actin spikes, with the majority of cells displaying straight edges similar to cells within the monolayer (Figure 6C and D) . Upon closer examination, minimal or no filopodia were observed in the leading edge cells ( Figure 6D ).
Discussion
Cell migration is essential in many physiological and pathological processes such as embryogenesis, wound healing, and metastasis (Coulombe, 2003; Keller, 2005; Yang and Weinberg, 2008) . In the context of cutaneous wound healing, epithelial cell migration is an essential step in tissue repair (O'Toole and Mellerio, 2010) . Due to impairment of wound healing processes, non-healing wounds are characterized by chronic inflammation, leading to accumulation of a variety of proteases at the wound site (Palolahti et al., 1993; Hiebert and Granville, 2012) . These proteases include matrix metalloproteinases, cathepsin G, neutrophil elastase and others (Palolahti et al., 1993; Grinnell and Zhu, 1996) , which collectively degrade many extracellular matrix proteins such as fibronectin, decorin, and vitronectin -all vital for proper wound healing. GzmB is also abundant at sites of chronic inflammation, including non-healing wounds, which cleaves a wide array of Confocal images of immunofluorescent staining of HaCaT cells for F-actin after creating a scratch with a pipette tip followed by a 6-h treatment with control (A and B) or 100 nm GzmB (C and D) and a 2-h stimulation with 100 ng/ml EGF. DAPI used as nuclear stain. Scale bars individually defined. White arrows point toward cells with evident filopodia. White boxes define areas represented in (B) and (D). Representative images picked from three independent experiments. extracellular substrates, including the abovementioned proteins (Hiebert and Granville, 2012) . Previous studies have highlighted the negative roles of GzmB in mouse models of chronic inflammation and impaired wound healing. Using ApoE knockout mice, Hiebert et al. demonstrated that GzmB/ApoE double knockout mice exhibited improved wound closure and contraction in comparison to ApoE knockout mice. GzmB inhibition with Serpina3n resulted in faster wound closure, improved re-epithelialization, and granulation tissue formation in a diabetic mouse model of impaired wound healing (Hsu et al., 2014) . While inflammatory infiltrates are a large source of GzmB (Hiebert and Granville, 2012) , through different mouse models, it has also been established that mast cells also serve as a significant source of GzmB (Pardo et al., 2007; Hsu et al., 2014; Parkinson et al., 2015; Shen et al., 2016) .
Wound healing is a complex interplay of cellular and extracellular matrix interactions, as many processes overlap and are interdependent on each other. This study investigated the effect of GzmB on epithelial cell migration -the core process involved in the re-epithlialization stage, with HaCaT keratinocytes used as an in vitro model for skin epithelium. While cell migration is a process driven by many factors including extracellular matrixderived granulation tissue, growth factor stimulation, and cell-to-cell contact rearrangement, this study focused on the growth factor dependent migration process. EGFR is a potent inducer of cell migration and proliferation (Haase et al., 2003; Harris et al., 2003) . During physiological wound healing platelets and macrophages serve as initial sources of EGF during hemostasis and inflammatory stage, respectively (Schultz et al., 1991) . In later stages, EGF is released from the surface of keratinocytes by ectodomain shedding in order to stimulate cell migration in an autocrine manner for induction of a local effect (Harris et al., 2003) . Due to the presence of protease generated extracellular matrix fragments, proteases, and necrotic cell debris, the bioavailability of EGF at the wound site is believed to be compromised (Hardwicke et al., 2008) . For this reason clinical trials using topical EGF therapy have been attempted, many of which showed no or marginal improvements with EGF treatment, and while few show promising results, there is still a long term concern of inducing skin malignancies as well as making the therapies financially viable (Hardwicke et al., 2008) . Increasing the bioavailability of EGF that is already in the wound and preventing EGFR signaling impairment may be a promising therapy for non-healing wounds.
The present study demonstrates that GzmB inhibits migration in HaCaT keratinocytes through an EGFR-dependent pathway. GzmB treatment alone and, interestingly, followed by EGF stimulation impaired keratinocyte migration significantly. While GzmB treatment alone fully prevented migration measured by ECIS, it significantly delayed migration induced by EGF. Cell migration rescue after 8 h may be due to GzmB internalization by cells, thus reducing the concentration of enzyme in the medium. Extracellular GzmB concentration declined in a time-dependent manner after addition to HaCaT cells, and intracellular compartments positive for GzmB staining were observed inside the cells after 6 h (Supplementary Figure 2 ). These findings are consistent with studies where GzmB was found within cellular compartments and without the addition of perforin, did not display cytotoxic capabilities (Pinkoski et al., 1998) . To investigate the effect of GzmB on EGFR signaling, tyrosine 1068 was chosen as an indicator of P-EGFR state as it was previously shown to be one of the essential phospho-tyrosines involved in migratory signaling pathways (Boucher et al., 2011) . GzmB treatment induced a dose-dependent reduction in P-EGFR levels, in both HaCaT and HeLA cells, with Serpin a3n leading to restoration of normal P-EGFR levels in HaCaT cells. Interestingly, GzmK, another member of the Granzyme family, did not reduce P-EGFR levels. This data suggests that reduced P-EGFR is a GzmB-specific effect and may be applicable to different epithelial cell types.
As cells transition into a migratory state, they undergo changes in morphology. Upon receiving an external migration-inducing signal cells undergo polarization, membrane spreading and extension, and protrusion in the direction of movement (Etienne-Manneville and Hall, 2002; Horwitz and Webb, 2003) . In a migrating monolayer of cells, only edge cells display migratory morphology, while the rest retract in support of collective cell movement (Horwitz and Webb, 2003) . While some cell types will form strong attachments to the substrate during migration, others, such as keratinocytes, do not form noticeable attachments but, rather, glide over the surface (Horwitz and Webb, 2003) . In migrating cells the nucleus gets displaced in the direction opposite from that of migration (Etienne-Manneville and Hall, 2002; Horwitz and Webb, 2003) . The present study showed that GzmB treatment impairs the induction of EGF-induced migratory cell phenotype further indicating that GzmB is interferes with cellular migration physiology. Further actin cytoskeleton staining revealed a reduction in filopodia formation in GzmB-treated cells while untreated cell exhibited an abundance of filopodia along the leading edge cell membranes (Figure 6 ). This difference in cytoskeletal architecture presents an interesting avenue for future investigations.
Previous studies indicate that GzmB can induce cell death through anoikis in the absence of perforin (Choy et al., 2004; Buzza et al., 2005) . With keratinocytes, however, we found no loss of cell viability after 24 h of treatment with 100 nm GzmB. Similar to other types of epithelial cells, HaCaT cells are able to undergo anoikis, as previously reported (Frisch et al., 1996; Bretland et al., 2001 ). However, treatment and incubation times used in this study did not induce anoikis ( Figure 5) . Similarly, anoikis was not observed in HeLa cells, consistent with previous findings (Choy et al., 2004) . It is likely that these cells would undergo anoikis at higher GzmB concentrations, however, GzmB concentrations greater than those used in this study could exceed physiologically relevant levels. Previous studies showed that capase-3, and to the lesser extent caspase-7, cleave EGFR intracellularly, which would lead to P-EGFR reduction (Bae et al., 2001; He et al., 2006) . Demonstrating the P-EGFR reduction in response to GzmB in caspase-3 deficient MCF-7 cells further ruled out cell death-mediated P-EGFR reduction. It is unlikely that caspase-7 is induced in HaCaT cells, as cells were viable for the duration of GzmB treatments. While the data in HaCaT cells contradicts previous reports in other cell types, it can be attributed to a higher degree of adherence to substratum and neighboring cells by keratinocytes (Hormia et al., 1995) .
GzmB has the ability to cleave many extracellular substrates and has overlapping roles with matrix metalloproteinases, and caspases (Buzza et al., 2005; Hiebert and Granville, 2012) . EGFR has previously been reported to be a matrix metalloproteinase substrate (Wilken et al., 2013) , and while we originally hypothesized a GzmB cleavage site on EGFR, we did not identify EGFR as a substrate of GzmB. Though the mechanism of action of GzmB on EGFR-dependent migration still remains elusive, this study demonstrates a novel role of GzmB on cell migration. Elucidating how GzmB affects the EGFR signaling pathway would shed further light with respect to the deleterious roles of GzmB in the wound healing process.
Materials and methods
Cells and tissue culture
HaCaT human keratinocyte cell line was obtained from AddexBio (San Diego, CA, USA). HeLa cervical cancer cell line was obtained from ATCC (Manassas, VA, USA). MCF7 caspase-3-deficient breast cancer cell line was obtained from Kevin Bennewith (BC Cancer Research Center, Vancouver, BC, Canada) . All cell lines were grown in DMEM (LifeTechnologies, Franklin, MA, USA) supplemented with 10% FBS and 1% penicillin and strepto micin (LifeTechnologies, Franklin, MA, USA) at 37 o C in 5% CO 2 incubator, unless indicated otherwise.
Reagents and antibodies
Antibodies for P-EGFR (Y1068), total EGFR, and GapDH were obtained from Cell Signaling (Danvers, MA, USA). Antibody for GzmB was obtained from BD Biosciences (San Jose, CA, USA). Antibody for p53 was obtained from Santa Cruz Biotechnology (Dallas, TX, USA). EGF and EGFR N-terminal domain peptides were obtained from LifeTechnologies (Franklin, MA, USA). EGFR N-terminus antibody obtained from Abcam (Toronto, ON, Canada). Secondary antibody used in Western immunoblotting, goat anti-rabbit-AlexaFluor 680, was obtained from LifeTechnologies (Franklin, MA, USA). In immunofluorescence experiments Goat anti-Rabbit-AlexaFluor 488 (LifeTechnologies, Franklin, MA, USA) and Donkey anti-MouseAlexaFluor 532 (LifeTechnologies, Franklin, MA, USA) were used for detection. GzmB was obtained from Emarald Bio (Bainbridge, WA, USA). Serpin a3n was obtained from Dr. R. Chris Bleackley, University of Alberta, Edmonton, AB, Canada.
Electric cell-substrate impedance sensing
HaCaT cell migration was measured using the ECIS method. Cells were seeded on L-cysteine pre-coated 8W1E PET ECIS arrays (Applied Biophysics, Troy, NY, USA) at 2 × 10 5 cells/chamber in 400 μl of DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were incubated for 1 h at RT to allow attachment, and afterwards incubated overnight at 37°C, 5% CO 2 tissue culture incubator on the ECIS Ztheta Platform (Applied Biophysics, Troy, NY, USA) with electric fence on. Electric fence settings were set to default and measurements were taken at multiple frequencies. On the next day cells were washed with PBS and incubated with serum free DMEM±100 nm GzmB±300 nm Sa3n for 6 h at 37°C. At the end of the 6-h incubation fresh medium±GzmB±Sa3n was added to cells and 100 ng/ ml EGF was added to specific wells. Cells were put back on the ECIS platform and electric fence was turned off to initiate migration. The time point when electric fence was turned off is referred to as 0 h. Migration was measured by an increase in resistance values at the frequency of 4 kHz in real time as cells covered the electrode. Every assay contained a well without cells and a well without electric fence as endogenous controls. PBS was used as control treatment.
Scratch migration assay
Cell migration was alternatively assayed using a traditional scratch assay method. HaCaT cells were seeded on 12-well tissue culture plates at 5 × 10 5 cells/well. The next morning cells were pre-treated with 100 nm GzmB for 6 h in serum free medium. Cells were then scratched with a p200 pipette tip, washed with PBS, and serum free medium containing fresh GzmB±100 ng/ml EGF was added. Immediately cells were imaged at 20× magnification using a light microscope. A scratch mark was made with a razor blade on the bottom of each well to serve as reference point for imaging. Cells were also imaged at 18 h after the addition of EGF. ImageJ (National Institutes of Health, Bethesda, MD, USA) was used to trace scratches and measure their area in pixels. Percent original area at 18 h was calculated relative to the area at the time of scratching.
Immunofluorescence
HaCaT cells were grown to confluency on an 8-well Lab Tek II chamber slide system (Nunc, Roskilde, Denmark) and serum starved overnight. In the morning, cells were washed with PBS, scratched with a p200 pipet tip, and treated with 100 nm GzmB for 6 h. Next 100 ng/ml EGF was added to the cell medium for 2 h. Cells were then washed with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton-X-100 (Sigma-Aldrich, St. Louis, MO, USA), blocked with 1% BSA and stained for EGFR and GzmB. Alternatively, cells were stained for F-actin using Phalloidin-AlexaFluor 488 (ThermoFisher) following manufacturer's protocol. Confocal imaging was performed on a Leica AOBS SP2 laser scanning confocal microscope (Leica, Heidelberg, Germany) and a Leica Confocal Software TCS SP2 (Leica, Heidelberg, Germany). Images were analyzed using Volocity 3D Image Analysis Software (PerkinElmer, Waltham, MA, USA).
Western immunoblotting
Cells grown to about 80% confluency were serum starved overnight and treated with 25-300 nm GzmB±Sa3n in serum free medium for 6 h and stimulated with 100 ng/ml EGF for 10 min. Cycloheximide (Sigma-Aldrich, St. Louis, MO, USA), 10 μg/ml) was used to block protein synthesis prior to GzmB treatment. Supernatants were collected and cells were lysed immediately using Cell Lytic M Solution (SigmaAldrich, St. Louis, MO, USA) supplemented with Protease Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO, USA) and Phosphatase Inhibitor Cocktail (Sigma-Aldrich, St. Louis, MO, USA). Protein amount in lysates was quantified using the Bio-Rad Protein assay (Bio-Rad Laboratories, Berkeley, CA, USA) and equal amounts of protein were used. Supernatants were concentrated in 10K spin columns ( Millipore, Billerica, MA, USA) and the entire sample was used in SDS-PAGE. Samples were denatured, ran on 10% polyacrylamide gel, transferred to PVDF membrane (Bio-Rad Laboratories, Berkeley, CA, USA), immunoblotted, and scanned using the Odyssey Infrared Imaging System (LI-COR Biotechnology, Lincoln, NE, USA). ImageJ was used to perform semi-quantitative band intensity analysis.
Biochemical cleavage assays
EGF (6 μg) or an extracellular domain of EGFR (500 ng) were incubated with 100 nm GzmB in PBS, with total reaction volume of 30 μl. GzmB was pre-incubated with 300 nm Serpina3n for 1 h at 37°C prior to addition to substrates. Cleavage reactions were incubated at 37°C for 24 h. Denaturing sample buffer was added to stop reactions. Samples were run on SDS-PAGE and were used in western immunoblotting or gel staining with SimplyBlue Stain (Invitrogen, Franklin, MA, USA) following manufacturer's protocol.
Flow cytometry
Cells were treated with GzmB for 6 h, collected using TrypLE (Gibco, Franklin, MA, USA), washed with cold PBS, and stained with AnnexinV AlexaFluor 488 (LifeTechnologies, Franklin, MA, USA) following manufacturer's protocol. Cells were analyzed on a Gallios Flow Cytometer (Beckman Coulter, Brea, CA, USA) and Kaluza Analysis Software version 1.3 (Beckman Coulter, Brea, CA, USA) was used for data analysis.
Calcein viability assay
HaCaT cells were seeded at 2 × 10 4 cells/well on black 96-well tissue culture plates (Greiner). Cells were serum starved the next day and then treated with 0.1-200 nm GzmB for 6 and 24 h. Dead cells controls were incubated with 70% methanol for 30 min. At the end of each treatment cells were washed with PBS, and incubated with 4 μm Calcein-AM (LifeTechnologies, Franklin, MA, USA) for 10 min at RT. Cells were then washed and incubated with 100 μl PBS. Fluorescent measurements were taken using a Tecan Infinite M1000 Pro plate reader (Tecan Group, Männedorf, Switzerland).
Statistical analyses
All data represent results from at least three independent experiments. ECIS and Scratch assay data was analyzed with ANOVA followed by Tukey's multiple comparison test. Data is represented as mean±standard error. The Mann-Whitney test (two-tailed, unpaired) was used to make two-group comparisons. p-Value are represented as follows: p < 0.05 is denoted by *, p < 0.001 is denoted by **, p < 0.0001 is denoted by ***, and p < 0.05 was considered significant in all experiments. All statistical analyses were performed using GraphPad Prism version 5.04 (GraphPad Software, San Diego, CA, USA).
